TrialDiabetes care2019

Efficacy and Safety of Empagliflozin in Renal Transplant Recipients With Posttransplant Diabetes Mellitus.

Thea Anine Strøm Halden et al.PubMed ↗Publisher ↗

No numbers read from the abstract.